The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 29, 2019
Filed:
Aug. 25, 2016
Applicant:
Santen Pharmaceutical Co., Ltd., Osaka-shi, Osaka, JP;
Inventors:
Kenji Kawashima, Osaka, JP;
Yusuke Yamazaki, Ikoma, JP;
Shinji Takaoka, Ikoma, JP;
Daisuke Shii, Osaka, JP;
Tomoko Oda, Ikoma, JP;
Takahiro Matsuyama, Ikoma, JP;
Assignee:
SANTEN PHARMACEUTICAL CO., LTD., Osaka-Shi, Osaka, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 241/44 (2006.01); C07D 403/12 (2006.01); C07F 9/6509 (2006.01); A61K 31/498 (2006.01); A61K 31/5377 (2006.01); A61K 31/675 (2006.01); A61P 27/02 (2006.01); A61P 29/00 (2006.01);
U.S. Cl.
CPC ...
C07D 241/44 (2013.01); A61K 31/498 (2013.01); A61K 31/5377 (2013.01); A61K 31/675 (2013.01); A61P 27/02 (2018.01); A61P 29/00 (2018.01); C07D 403/12 (2013.01); C07F 9/650994 (2013.01);
Abstract
The present invention relates to a novel [4-(1,3,3-trimethyl-2-oxo-3,4-dihydro-1H-quinoxalin-7-yl)phenoxy]ethyloxy compound or a salt thereof. The compound or a salt thereof of the present invention has a glucocorticoid receptor agonist activity, and is useful as a medicine, in particular as a prophylactic or therapeutic agent for the glucocorticoid receptor related disease.